Asmanex HFA is a prescription inhaler used for the long-term maintenance treatment of asthma in people aged 5 and older. It contains mometasone furoate, an inhaled corticosteroid that reduces inflammation in the airways to prevent asthma symptoms before they start. It is not a rescue inhaler and will not help during an asthma attack already in progress.
How Asmanex HFA Works
Asthma involves chronic inflammation in the airways. Even when you feel fine, immune cells in the lungs can be in a state of low-level overreaction, ready to trigger swelling, mucus production, and airway tightening at the slightest provocation. Asmanex HFA delivers a corticosteroid directly to the lungs, where it suppresses the activity of several types of immune cells and the chemical signals they release. Over time, this calms the airways and makes them less likely to react to triggers like allergens, cold air, or exercise.
This is a preventive medication, not an emergency one. You take it on a regular schedule whether or not you’re having symptoms. Most people notice some improvement within the first week or two, but it can take longer to reach full benefit. Because of this gradual onset, you still need a separate fast-acting rescue inhaler for sudden symptoms or flare-ups.
Available Strengths and Who Can Use It
Asmanex HFA comes in three strengths:
- 50 mcg per puff, for children ages 5 to 11
- 100 mcg per puff, for patients 12 and older
- 200 mcg per puff, for patients 12 and older
Each canister contains 120 metered doses. Your prescribed strength depends on your age, asthma severity, and whether you were previously using another corticosteroid. The medication has not been studied in children under 5, so it is not approved for that age group.
Asmanex HFA vs. Asmanex Twisthaler
Both products contain the same active ingredient, but they use different delivery systems. Asmanex HFA is a pressurized metered-dose inhaler (MDI), the classic “press and breathe” canister type. The Asmanex Twisthaler is a dry powder inhaler (DPI) that releases medication when you inhale sharply through the device. The choice between them often comes down to which device a patient can use effectively. Young children and people who have trouble generating a strong inhalation may do better with the HFA, since it propels the medication into the lungs rather than relying entirely on the patient’s breath.
How to Use and Maintain the Inhaler
Before using Asmanex HFA for the first time, you need to prime it. Hold the inhaler upright, point it away from your face, shake it, and press down firmly on the canister to release one puff. Repeat this for a total of four puffs sprayed into the air. If you go more than 5 days without using the inhaler, prime it again before your next dose.
After each use, rinse your mouth with water and spit it out. This simple step helps prevent oral thrush, a fungal infection that can develop when corticosteroid residue sits on the tissues of the mouth and throat. It also reduces the chance of hoarseness.
Clean the mouthpiece every 7 days by wiping the inside and outside with a dry, lint-free cloth. Do not wash the inhaler or put any part of it in water, and never try to clear a blockage with a pin or sharp object. Keep the canister in the actuator at all times.
Common Side Effects
The most frequently reported side effect is headache, occurring in roughly 17 to 22 percent of patients in clinical trials, though the placebo groups showed similar rates (around 20 percent), so headaches may not always be caused by the medication itself. Oral thrush is more clearly linked to the drug, appearing in about 4 to 6 percent of patients compared to 2 percent on placebo. Rinsing your mouth after each dose significantly lowers that risk.
Less common side effects, reported in 1 to 3 percent of patients, include hoarseness, nosebleeds, nasal irritation, and dry throat. Hoarseness tends to improve with consistent mouth rinsing and sometimes resolves on its own as your body adjusts.
Important Safety Information
Asmanex HFA is specifically contraindicated during status asthmaticus, a severe asthma emergency. It cannot open airways that are already constricted. If your asthma suddenly worsens or your rescue inhaler stops providing relief, that is a medical emergency requiring immediate treatment, not an extra dose of your maintenance inhaler.
Because inhaled corticosteroids suppress local immune activity in the airways, long-term use carries a small risk of respiratory infections and, in children, a potential effect on growth velocity. These risks are generally considered manageable compared to the dangers of uncontrolled asthma, but they are worth discussing with your prescriber, especially for pediatric patients who will be on the medication for years.
Switching to Asmanex HFA from oral corticosteroids (like prednisone) requires a careful, gradual taper. Stopping oral steroids abruptly when transitioning to an inhaled form can cause adrenal insufficiency, a condition where the body cannot produce enough of its own stress hormones. Your prescriber will typically reduce the oral dose slowly over weeks while the inhaled medication takes effect.